Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury

Acute kidney injury (AKI) is a common and independent risk factor for death and chronic kidney disease (CKD). Despite promising preclinical data, there is no evidence that antioxidants reduce the severity of injury, increase recovery, or prevent CKD in patients with AKI. Pyridoxamine (PM) is a struc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Physiol Renal Physiol
Hlavní autoři: Skrypnyk, Nataliya I., Voziyan, Paul, Yang, Haichun, de Caestecker, Christian R., Theberge, Marie-Claude, Drouin, Mathieu, Hudson, Billy, Harris, Raymond C., de Caestecker, Mark P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Physiological Society 2016
Témata:
Call for Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008672/
https://ncbi.nlm.nih.gov/pubmed/27194713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00056.2016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky